This article describes 2 innovative models of advanced practice provider-led medication for opioid use disorder treatment programs offering comprehensive, interprofessional care for pregnant patients and provides implications for broader adaptation of practice. Increasing the number of midwives and nurse practitioners waivered to prescribe buprenorphine and able to connect pregnant patients with opioid use disorder to appropriate community-based resources, treatment, and self-help programs could address alarming substance use trends including overdose deaths and other sequelae associated with the opioid epidemic.
Keywords: US Substance Abuse and Mental Health Services; buprenorphine; harm reduction; maternal health services; midwives; nurse practitioners; opioid-related disorders; pregnant women; prenatal care.
© 2022 by the American College of Nurse-Midwives.